{
  "id": "5bec069d-1e19-4daf-95c4-0ddb0dbcd527",
  "university": "PCI",
  "regulation": "Master",
  "course": "B.Pharm",
  "effective_year": null,
  "curriculum_type": "pci",
  "curriculum_data": {
    "years": [
      {
        "year": 4,
        "semesters": [
          {
            "semester": 8,
            "subjects": [
              {
                "code": "BP805T",
                "name": "Pharmacovigilance",
                "type": "theory",
                "category": "elective",
                "units": [
                  {
                    "number": "Unit I",
                    "title": "Introduction to Pharmacovigilance and Adverse Drug Reactions",
                    "topics": [
                      "History of Pharmacovigilance",
                      "Development of Pharmacovigilance",
                      "Importance of safety monitoring of Medicine",
                      "WHO international drug monitoring programme",
                      "Pharmacovigilance Program of India(PvPI)",
                      "Definitions of adverse drug reactions (ADRs)",
                      "Classification of adverse drug reactions (ADRs)",
                      "Detection of adverse drug reactions",
                      "Reporting of adverse drug reactions",
                      "Methods in Causality assessment",
                      "Severity assessment of ADRs",
                      "Seriousness assessment of ADRs",
                      "Predictability assessment of ADRs",
                      "Preventability assessment of ADRs",
                      "Management of adverse drug reactions",
                      "Terminologies of adverse medication related events",
                      "Regulatory terminologies in pharmacovigilance"
                    ]
                  },
                  {
                    "number": "Unit II",
                    "title": "Drug and Disease Classification, Coding, and Programme Establishment",
                    "topics": [
                      "Anatomical classification of drugs",
                      "Therapeutic classification of drugs",
                      "Chemical classification of drugs",
                      "International classification of diseases",
                      "Daily defined doses",
                      "International Non proprietary Names for drugs",
                      "WHO adverse reaction terminologies",
                      "MedDRA",
                      "Standardised MedDRA queries",
                      "WHO drug dictionary",
                      "Eudravigilance medicinal product dictionary",
                      "Basic drug information resources",
                      "Specialised resources for ADRs",
                      "Establishing pharmacovigilance programme in a hospital",
                      "Establishment of drug safety department in industry",
                      "Operation of drug safety department in industry",
                      "Contract Research Organisations (CROs)",
                      "Establishing a national pharmacovigilance programme"
                    ]
                  },
                  {
                    "number": "Unit III",
                    "title": "Vaccine Safety, Methods, and Communication",
                    "topics": [
                      "Vaccine Pharmacovigilance",
                      "Vaccination failure",
                      "Adverse events following immunization",
                      "Passive surveillance",
                      "Spontaneous reports",
                      "Case series",
                      "Stimulated reporting",
                      "Active surveillance",
                      "Sentinel sites",
                      "Drug event monitoring",
                      "Registries",
                      "Comparative observational studies",
                      "Cross sectional study",
                      "Case control study",
                      "Cohort study",
                      "Targeted clinical investigations",
                      "Effective communication in Pharmacovigilance",
                      "Communication in Drug Safety Crisis management",
                      "Communicating with Regulatory Agencies",
                      "Communicating with Business Partners",
                      "Communicating with Healthcare facilities",
                      "Communicating with Media"
                    ]
                  },
                  {
                    "number": "Unit IV",
                    "title": "Safety Data Generation and ICH Guidelines",
                    "topics": [
                      "Safety data generation in Pre clinical phase",
                      "Safety data generation in Clinical phase",
                      "Safety data generation in Post approval phase (PMS)",
                      "Organization of ICH",
                      "Objectives of ICH",
                      "Expedited reporting",
                      "Individual case safety reports",
                      "Periodic safety update reports",
                      "Post approval expedited reporting",
                      "Pharmacovigilance planning",
                      "Good clinical practice in pharmacovigilance studies"
                    ]
                  },
                  {
                    "number": "Unit V",
                    "title": "Pharmacogenomics, Special Populations, CIOMS and CDSCO",
                    "topics": [
                      "Pharmacogenomics of adverse drug reactions",
                      "Genetics related ADR with example focusing PK parameters",
                      "Drug safety evaluation in Paediatrics",
                      "Drug safety evaluation in Pregnancy",
                      "Drug safety evaluation in lactation",
                      "Drug safety evaluation in Geriatrics",
                      "CIOMS Working Groups",
                      "CIOMS Form",
                      "CDSCO (India) and Pharmacovigilance",
                      "D&C Act and Pharmacovigilance",
                      "Schedule Y and Pharmacovigilance",
                      "Differences in Indian and global pharmacovigilance requirements"
                    ]
                  }
                ]
              }
            ]
          }
        ]
      }
    ],
    "university": "Generic University",
    "regulation": "PCI Regulation",
    "course": "B.Pharm"
  },
  "stats": {
    "years": 4,
    "semesters": 8,
    "subjects": 1,
    "units": 5,
    "topics": 80,
    "theory": 1,
    "practical": 0,
    "electives": 0
  },
  "status": "active",
  "created_at": "2025-12-16T07:09:52.723360+00:00",
  "updated_at": null
}